![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Broadcom
AVGO
Taiwan Semiconductor
TSM
Tesla
TSLA
ASML Holding
ASML
Qualcomm
QCOM
US Stock MarketDetailed Quotes
SIGA SIGA Technologies
- 6.180
- +0.030+0.49%
Close Dec 13 16:00 ET
- 6.180
- 0.0000.00%
Post 20:01 ET
441.28MMarket Cap5.15P/E (TTM)
6.340High5.940Low427.85KVolume6.180Open6.150Pre Close2.61MTurnover1.06%Turnover Ratio6.51P/E (Static)71.40MShares12.83052wk High2.60P/B249.43MFloat Cap3.96852wk Low--Dividend TTM40.36MShs Float23.227Historical High--Div YieldTTM6.50%Amplitude3.202Historical Low6.092Avg Price1Lot Size
SIGA Technologies Stock Forum
Sign in to post a comment
$SIGA Technologies (SIGA.US)$
Wow almost bought in too...
SIGA Technologies (SIGA) Shares Tumble After Mpox Therapy Fails, Chief Medical Officer Terminated - Hagens Berman
phew
Wow almost bought in too...
SIGA Technologies (SIGA) Shares Tumble After Mpox Therapy Fails, Chief Medical Officer Terminated - Hagens Berman
phew
1
$SIGA Technologies (SIGA.US)$ 👀like finalizing W-Pattern just below TWAP if strong close above may be golden cross or preparation for multi -days runs 🏃 whatever opportunities goes and comes around always awaiting confirmation
7
$SIGA Technologies (SIGA.US)$
SIGA Enters into Exclusive License Agreement with Vanderbilt University for Novel Poxvirus Monoclonal Antibodies
SIGA Technologies (NASDAQ: SIGA) has entered into an exclusive license agreement with Vanderbilt University for a portfolio of preclinical fully human monoclonal antibodies (mAbs). These mAbs have potential as treatments for a broad range of orthopoxviruses, including smallpox and mpox. The agreement grants SIGA exclusive rights to develop, manufacture...
SIGA Enters into Exclusive License Agreement with Vanderbilt University for Novel Poxvirus Monoclonal Antibodies
SIGA Technologies (NASDAQ: SIGA) has entered into an exclusive license agreement with Vanderbilt University for a portfolio of preclinical fully human monoclonal antibodies (mAbs). These mAbs have potential as treatments for a broad range of orthopoxviruses, including smallpox and mpox. The agreement grants SIGA exclusive rights to develop, manufacture...
1
$SIGA Technologies (SIGA.US)$ Reuters· 3 mins ago
SIGA Technologies Inc - Contract in Response to Morocco Ministry of Health Request. Makes first commercial sale in Africa
SIGA Technologies Inc - Contract in Response to Morocco Ministry of Health Request. Makes first commercial sale in Africa
1
3
$SIGA Technologies (SIGA.US)$
wow, finally increasing a little... wondering if it's best to wait for before earnings report to buy in
wow, finally increasing a little... wondering if it's best to wait for before earnings report to buy in
2
No comment yet
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Lnova : What do you think about the stock that I saw browny shared this week, I was thinking maybe mpox could also be a catalyst for
. Then again I’m not sure how far their product is in its development. One sec
Jaguar8 OP Lnova : I don’t know what he posted
Lnova Jaguar8 OP : One sec, it’s $Polyrizon (PLRZ.US)$ , I noticed in their company profile, “The company is a biotechnology company in clinical development that specializes in developing innovative hydrogels provided in the form of nasal sprays and creating a thin hydrogel-based barrier in the nasal cavity that can provide a barrier against viruses and allergens coming into contact with nasal epithelial tissue. The company's proprietary C&C hydrogel technology consists of a mixture of natural building blocks, provided as a nasal spray, and has the potential to serve as a ‘biological mask’ with a thin shielding barrier in the nasal cavity.”
Lnova : plzr product may still be in development stage, but, I was intrigued by their product description. So it’s one company I will keep an eye on, especially with viruses/pandemics, etc.
Lnova Jaguar8 OP : sorry btw I don’t mean to spam you lol. I just found the product they’re developing to be interesting
View more comments...